Is it really molecular guided surgery (or just EPR effect)? Understanding and overcoming the effects of cancer physiology on tumor contrast (Conference Presentation)

Ken M. Tichauer

doi:10.1117/12.2288385

14 March 2018 Is it really molecular guided surgery (or just EPR effect)? Understanding and overcoming the effects of cancer physiology on tumor contrast (Conference Presentation)

Ken M. Tichauer

Author Affiliations +

Proceedings Volume 10478, Molecular-Guided Surgery: Molecules, Devices, and Applications IV; 104780K (2018) https://doi.org/10.1117/12.2288385
Event: SPIE BiOS, 2018, San Francisco, California, United States

Abstract

Molecular guided surgery—employing injectable fluorescent imaging agents targeted to cancer-specific biomolecules—is advancing rapidly. However, cancer physiology, specifically blood flow, vascular permeability, and lymphatic drainage can significantly influence and even dominate how imaging agents are taken up and retained in cancerous tissue. Moreover, each of these physiological parameters can vary extensively from tumor-type to tumor-type, from patient-to-patient, and even within an individual’s cancer, making it impossible to know if tumor contrast is achieved through molecular targeting or enhanced permeability and retention (EPR) effect. Alternatively, if there is no contrast, there is no guarantee that the tissue is non-cancerous, only that there was no accumulation of imaging agent, which could be attributable to low blood flow or vascular permeability. This talk will explore the potential effects of cancer physiology on imaging agent uptake and retention in cancerous tissue and discuss methods such as paired-agent imaging, which work to account for tumor physiology variability to achieve true molecular guided surgery.

Conference Presentation

Citation Download Citation

Ken M. Tichauer "Is it really molecular guided surgery (or just EPR effect)? Understanding and overcoming the effects of cancer physiology on tumor contrast (Conference Presentation)", Proc. SPIE 10478, Molecular-Guided Surgery: Molecules, Devices, and Applications IV, 104780K (14 March 2018); https://doi.org/10.1117/12.2288385

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
PRESENTATION

WATCH
PRESENTATION SAVE TO MY LIBRARY

GET CITATION

KEYWORDS

Cancer

Tumors

Physiology

Surgery

Tissues

Blood circulation

Luminescence

Show All Keywords

Keywords/Phrases

Search In:

Publication Years